MolNFT v1 · #22704 · protein
Structure of SER130GLY shv-1 beta-lactamase
1TDL · Beta-lactamase shv-1: “Structure of SER130GLY shv-1 beta-lactamase”. X-ray diffraction, 1 ligand (MA4), 2 pockets (best druggability 0.68). MolNFT v1 #22704 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 1TDL
- Type
- protein
- Length
- 265 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactamase shv-1
- EC
- 3.5.2.6
- UniProt
- P14557
- Ligands
- MA4
- Pockets
- 2 · best druggability 0.68
Structure
x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactamase shv-1 (EC 3.5.2.6) | protein | 265 | 45% helix, 17% strand | P14557 |
Ligands and binding sites
- MA4 · Cyclohexyl-hexyl-beta-D-maltoside · ligand · 2 copies · chains A
- EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 213 | 0.68 | 0.85 | 24 | MA4 |
| 2 | 74 | 0.33 | 0.75 | 16 | EPE |
Modifications
Observed in the structure: 1 disulfide (disulfide).
Compared structures
- 1TDL · Structure of Ser130Gly SHV-1 beta-lactamase · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P14557
- Elsewhere: RCSB PDB 1TDL · PDBe 1TDL · UniProt P14557
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.